Selçuk Kırlı

1.4k total citations
40 papers, 1.1k citations indexed

About

Selçuk Kırlı is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Selçuk Kırlı has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 9 papers in Pharmacology and 7 papers in Experimental and Cognitive Psychology. Recurrent topics in Selçuk Kırlı's work include Treatment of Major Depression (7 papers), Stress Responses and Cortisol (6 papers) and Schizophrenia research and treatment (5 papers). Selçuk Kırlı is often cited by papers focused on Treatment of Major Depression (7 papers), Stress Responses and Cortisol (6 papers) and Schizophrenia research and treatment (5 papers). Selçuk Kırlı collaborates with scholars based in Türkiye, United Kingdom and Saudi Arabia. Selçuk Kırlı's co-authors include Emre Sarandöl, Aslı Sarandöl, Salih Saygın Eker, Ebru Vatansever, Selda Erdinç, Cengiz Akkaya, Güven Özkaya, Mecit Çalışkan, Şengül Cangür and Melahat Dirican and has published in prestigious journals such as SHILAP Revista de lepidopterología, Schizophrenia Research and Journal of Psychiatric Research.

In The Last Decade

Selçuk Kırlı

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Selçuk Kırlı Türkiye 14 493 347 242 159 152 40 1.1k
Aslı Sarandöl Türkiye 14 404 0.8× 279 0.8× 210 0.9× 113 0.7× 157 1.0× 52 989
Mahmut Bulut Türkiye 18 564 1.1× 295 0.9× 375 1.5× 86 0.5× 175 1.2× 63 1.3k
Salih Saygın Eker Türkiye 11 336 0.7× 240 0.7× 137 0.6× 110 0.7× 103 0.7× 25 744
Heber Odebrecht Vargas Brazil 20 732 1.5× 353 1.0× 403 1.7× 118 0.7× 171 1.1× 43 1.4k
Cristinel Ștefănescu Romania 13 365 0.7× 219 0.6× 149 0.6× 133 0.8× 234 1.5× 49 1.2k
Mehmet Bekaroğlu Türkiye 8 365 0.7× 268 0.8× 279 1.2× 81 0.5× 102 0.7× 15 984
İ̇brahim Eren Türkiye 17 301 0.6× 186 0.5× 264 1.1× 94 0.6× 163 1.1× 70 1.3k
Jana Trebatická Slovakia 16 345 0.7× 252 0.7× 248 1.0× 73 0.5× 164 1.1× 25 1.1k
Mehmet Yumru Türkiye 11 392 0.8× 183 0.5× 419 1.7× 79 0.5× 97 0.6× 28 940
A. Mechri Tunisia 17 465 0.9× 210 0.6× 612 2.5× 93 0.6× 138 0.9× 60 1.5k

Countries citing papers authored by Selçuk Kırlı

Since Specialization
Citations

This map shows the geographic impact of Selçuk Kırlı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selçuk Kırlı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selçuk Kırlı more than expected).

Fields of papers citing papers by Selçuk Kırlı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selçuk Kırlı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selçuk Kırlı. The network helps show where Selçuk Kırlı may publish in the future.

Co-authorship network of co-authors of Selçuk Kırlı

This figure shows the co-authorship network connecting the top 25 collaborators of Selçuk Kırlı. A scholar is included among the top collaborators of Selçuk Kırlı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selçuk Kırlı. Selçuk Kırlı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taşkapılıoğlu, Özlem, et al.. (2018). The relationship between psychopathology, psychosocial adjustment, social support and quality of life in multiple sclerosis. The European Research Journal. 5(1). 20–28. 4 indexed citations
2.
Taşkapılıoğlu, Özlem, et al.. (2016). Psychopathology, Psychosocial Factors and Quality of Life in Patients with Myasthenia Gravis. 33(3). 482–493. 3 indexed citations
3.
Ercan, İlker, et al.. (2015). Examinando los puntajes de corte para el inventario de ansiedad estado-rasgo. REVISTA ARGENTINA DE CLINICA PSICOLOGICA. 24(2). 143–148. 10 indexed citations
4.
Eker, Salih Saygın, et al.. (2014). Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?. Acta Neuropsychiatrica. 26(5). 291–297. 11 indexed citations
5.
Uzbay, Tayfun, Gökhan Göktalay, Hakan Kayır, et al.. (2013). Increased plasma agmatine levels in patients with schizophrenia. Journal of Psychiatric Research. 47(8). 1054–1060. 49 indexed citations
6.
Akkaya, Cengiz, et al.. (2011). The Effects of Reboxetine and Venlafaxine on ECG Variables in Depressed Patients. SHILAP Revista de lepidopterología. 21(1). 11–17. 1 indexed citations
7.
Sarandöl, Emre, et al.. (2011). Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: A 24-week follow-up study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(5). 1284–1290. 132 indexed citations
8.
Akkaya, Cengiz, et al.. (2011). Metabolic, endocrinologic and cardiac effects of amisulpride: a 24-week follow-up study. Therapeutic Advances in Psychopharmacology. 1(6). 189–196. 10 indexed citations
9.
Eker, Salih Saygın, Cengiz Akkaya, Canan Ersoy, Aslı Sarandöl, & Selçuk Kırlı. (2010). Reversible escitalopram-induced hypothyroidism. General Hospital Psychiatry. 32(5). 559.e5–559.e7. 7 indexed citations
10.
Eker, Salih Saygın, Selçuk Kırlı, Cengiz Akkaya, Şengül Cangür, & Aslı Sarandöl. (2009). Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?. The World Journal of Biological Psychiatry. 10(4-2). 400–408. 6 indexed citations
11.
Eker, Salih Saygın, Cengiz Akkaya, Aslı Sarandöl, et al.. (2008). Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(4). 955–961. 32 indexed citations
12.
Akkaya, Cengiz, et al.. (2008). [Reliability and validity of the Turkish version of the Social Adaptation Self-Evaluation Scale (SASS)].. PubMed. 19(3). 292–9. 10 indexed citations
13.
Sarandöl, Aslı, et al.. (2007). Sociodemographic, disorder and treatment relatedcharacteristics affecting follow-up periods ofschizophrenic outpatients. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 17(1). 15–23. 1 indexed citations
14.
Sarandöl, Aslı, Emre Sarandöl, Salih Saygın Eker, et al.. (2007). Major depressive disorder is accompanied with oxidative stress: short‐term antidepressant treatment does not alter oxidative–antioxidative systems. Human Psychopharmacology Clinical and Experimental. 22(2). 67–73. 420 indexed citations
15.
Kırlı, Selçuk, et al.. (2007). The impact of ω-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: An open-label pilot study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(7). 1493–1499. 68 indexed citations
16.
Sarandöl, Aslı, et al.. (2006). Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(2). 548–550. 13 indexed citations
17.
Akkaya, Cengiz, et al.. (2006). Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study. Human Psychopharmacology Clinical and Experimental. 21(5). 337–345. 14 indexed citations
18.
Akkaya, Cengiz, et al.. (2006). A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30(8). 1535–1538. 13 indexed citations
19.
Sarandöl, Aslı, et al.. (2006). Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30(6). 1103–1108. 55 indexed citations
20.
Kırlı, Selçuk & Mecit Çalışkan. (1998). A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia. Schizophrenia Research. 33(1-2). 103–111. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aslı Sarandöl Breakdown of academic impact, for papers by Mahmut Bulut Breakdown of academic impact, for papers by Salih Saygın Eker Breakdown of academic impact, for papers by Heber Odebrecht Vargas Breakdown of academic impact, for papers by Cristinel Ștefănescu Breakdown of academic impact, for papers by Mehmet Bekaroğlu Breakdown of academic impact, for papers by İ̇brahim Eren Breakdown of academic impact, for papers by Jana Trebatická Breakdown of academic impact, for papers by Mehmet Yumru Breakdown of academic impact, for papers by A. Mechri
Rankless by CCL
2026